Waveform physiological data is important in the treatment of critically ill patients in the intensive care unit. Such recordings are susceptible to artefacts, which must be removed before the data can be re-used for alerting or reprocessed for other clinical or research purposes. Accurate removal of artefacts reduces both bias and uncertainty in clinical assessment and the false positive rate of intensive care unit alarms, and is therefore a key component in providing optimal clinical care. In this work, we present DeepClean; a prototype self-supervised artefact detection system using a convolutional variational autoencoder deep neural network that avoids costly and painstaking manual annotation, requiring only easily-obtained 'good' data for training. For a test case with invasive arterial blood pressure, we demonstrate that our algorithm can detect the presence of an artefact within a 10-second sample of data with sensitivity and specificity around 90%. Furthermore, DeepClean was able to identify regions of artefact within such samples with high accuracy and we show that it significantly outperforms a baseline principle component analysis approach in both signal reconstruction and artefact detection. DeepClean learns a generative model and therefore may also be used for imputation of missing data.
Introduction
Care of critically ill patients in the intensive care unit (ICU), who may experience life-threatening deterioration sometimes over minutes or even seconds, is highly dependent on data [1] , which, as a consequence, may be voluminous. Continuous physiological monitoring of signals, such as invasive arterial blood pressure (ABP), the electrocardiogram and other vascular or intracranial pressures, are an extreme example providing a wealth of complex, heterogeneous yet highly structured data at optimal sampling frequencies of 100Hz or even more.
In addition to being the basis of continuous clinical care, particularly in alerting the clinician to changes in real time, these physiological signals may be further processed to derive other useful parameters; for example, measures for tracking optimal cerebral autoregulation [2] and heart-rate variability [3] , which has repeatedly been shown to be a determinant of physiological integrity, as well as more sophisticated metrics based on non-linear dynamics [4] or information theory [5] that may form novel digital biomarkers for precision care in the future. Signal artefacts may reduce reliability in estimation of these derived parameters, confound analysis and create uncertainty in clinical decision making. Closely related is the handling of missing data, often treated using simple methods that are biased and underestimate variability, such as linear interpolation of observed data. Imputation methods offer a useful alternative [6] . An autoencoder network trains a parametric encoder and decoder simultaneously to learn a mapping that reconstructs the input via a sparse low-dimensional representation. The VAE instead learns a generative model, p θ (x t |z), and a variational approximation, q φ (z|x t ), to the posterior distribution for the latent variables, p θ (z|x t ), and we can generate new data by sampling from the latent and generative distributions in order. The weights of the encoder are the variational parameters, φ, are the weights of the decoder are the generative parameters, θ. The output of the encoder acts as a mean and standard deviation to the Gaussian variational distribution.
Artefact detection is also important for ICU alerting systems [7] and reduces the likelihood of false alarm incidents. A high rate of false alarms carries a significant risk as alarm fatigue often leaves clinical staff perceiving the alarms to be generally unhelpful and can therefore potentially result in delays to the appropriate clinical intervention [8] .
Artefact detection has traditionally been a difficult and costly task, requiring time-consuming human annotation or thresholding based on signal-specific feature engineering [9] , particularly as artefacts arise from a variety of internal and external sources, such as sensor noise, patient movement and clinical interventions. Due to the complex morphologies of signals, annotation by experienced clinicians remains a gold standard for ICU multimodality monitoring, despite inherent biases and issues with replicability. Many standard supervised learning methods require samples that are annotated in this way, though a recent study uses active learning to query and propose samples for annotation in an efficient manner [10] . An alternative unsupervised approach has foundations in spectral anomaly detection [11] . These methods seek an embedding of the data in an 'information bottleneck' lower-dimensional space where the anomaly or artefact is separated from the normal data, and then form a reconstruction of the input from its lower-dimensional representation back to the original input space. Embedding in the 'bottleneck' latent space is a lossy transformation and the aim is to capture salient features of the data whilst disregarding anomalous features. Subsequently, the reconstruction should restore the underlying 'true' behaviour and the error in the reconstruction, compared to the input, can then be used to discriminate artefacts. A traditional autoencoder (Figure 1a ) can be used for this purpose, though its latent space is in general neither meaningful nor well-structured, and it may have issues with fragility and overconfident prediction.
Framing the problem using variational methods yields a deep generative modelling approach that reproduces this 'bottleneck' architecture (Figure 1b) , called a variational autoencoder (VAE) [12] . The central assumption is that the data, {x t } N t=1 , is generated by a random process dependent on unobserved random variables or features, z, and the key idea that the VAE jointly learns a probability distribution for z and a generative model, p θ (x t |z), that describes the random process. Stochastic sampling from the variational distribution allows the model to abstract and generate new candidate data. During training, it learns both to encode some structure in the latent space and for these generated candidates to accurately reconstruct inputs that come from the same assumed underlying random process. This process enables it to discriminate artefacts despite never being explicitly exposed to any, since we assume different latent mechanisms govern the behaviour of artefacts within the signal and so model prediction over an input containing such an artefact will have low reconstruction probability and high reconstruction error [13] . For further detail, comprehensive summaries of the VAE can be found in [14] and [15] . 
(ii) (i) In order to learn a generative model describing 'clean' physiological waveforms, substantially 'clean' training data is required. However, we wish to obtain this without human mark-up at a beat-to-beat level. In our methodology, we simply first remove large, grossly abnormal sections by applying basic thresholding heuristics ( Figure 2 ). This is a far easier task than manual markup of the waveform and inevitably leaves artefacts in the training set. However, for a typical waveform recording, the proportion of such abnormal data across the whole dataset will generally be very small (assuming signal artefacts are rare in comparison to normal beats). With sufficient quantities of data, it is possible to set conservative thresholds such that the proportion of retained data containing an artefact is small, minimising their effect on the model.
Our model was trained and tested on 10-second windows of preprocessed data. This window size was chosen pragmatically, since such a segment will typically contain a small number of beats and we do not expect physiology to vary grossly over this period from clinical experience. Though our model is self-supervised, a labelled and balanced test set, with a similar proportion of artefacts and valid signals, was still required to determine model performance against manual expert mark-up. As regions marked as abnormal in preprocessing are likely to enriched with artefacts, we biased towards them when sampling to create this test set of 200 10-second samples. First, we split the data into 100-second windows and calculated the proportion of each window that had been marked in preprocessing ( Figure 2c ). Normalising across the whole dataset to give a discrete probability distribution, we sampled from this distribution to select a 100-second window that had greater chance of containing marked data. We then sampled uniformly within this selected window to determine a 10-second sample to join the test set, repeating this procedure until we had generated a test set of sufficient size. The test set and preprocessing-marked regions were then removed from the dataset and the remaining data split into 10-second samples, shuffled, and divided into training and validation sets with ratio 9:1. All three data sets (training, validation and test) were then standardised by the training set mean and standard deviation. Each 10-second test sample was labelled as either containing an artefact or being artefact free by expert review (T.E., A.E.) to enable us to assess sample-wide artefact detection performance. Furthermore, for cases containing an artefact, portions of the data judged to be invalid (artefactual) within each 10 second window were also marked-up to allow assessment of within-sample artefact detection performance.
Model specification and training
We built a variational autoencoder with deep convolutional neural networks (CNNs) for both encoder and decoder modules. CNNs allow the network to learn translation-invariant local patterns, with successive layers building a spatial hierarchy of increasing scale, a sensible approach in this context as physiological signal data is quasi-periodic and highly-structured. We fixed an encoder network architecture with three relatively small convolutional layers, alternated with two pooling layers to increase the receptive field, and finally two dense layers that split the network graph into separate branches for the two parameters that define the latent space. The decoder architecture mirrored this in reverse, with pooling replaced by up-sampling ( Figure 3 ). Both encoder and decoder contained approximately 20,000 trainable parameters. We then trained separate models with increasing latent space dimension. For each latent dimension, we repeated training five times, presenting the model that minimised the validation loss. To train DeepClean, we used an NVidia Pascal P100 GPU, with code written in python using the Keras library [16] with TensorFlow backend [17] .
We optimised against the evidence lower bound (ELBO), which naturally constrains the reconstruction (decoder) and enforces regularisation of the variational distribution (encoder). The regularisation term and latent sampling encourage the variational to place higher probability mass on a range of latent z values that could potentially have generated the input sample, preventing the network from collapsing the latent representation to a single point estimate with the maximal likelihood, and allowing almost identical inputs to have a similar representations and reconstructions. We made typical assumptions that the distributions of the prior, variational and conditional are all Gaussian. Further, we made the assumption that the prior is multivariate unit normal and that the conditional distribution is a factorised Gaussian with identical variances. This results in a well-structured latent space (Figure 4) , and, together with Monte Carlo stochastic approximations to the expectation terms, provides a tractable expression for the loss and its gradient, allowing stochastic gradient descent learning.
Baselines for assessing performance
We compared the performance of DeepClean to two baselines, a 'ground truth' manual annotation and a reconstruction via principal component analysis (PCA) dimensionality reduction. PCA is related to a traditional autoencoder in the simplest case with linear activations and the weights of the encoder network in this case span the same subspace as the principal components [19] . Dimensionality reduction with PCA is achieved by restricting the number of principal components and projecting the data onto these principal axes. This is comparable to the latent dimension of DeepClean and so we refer to the number of principal components as the latent dimension for brevity. An inverse transformation restores this projection to the original input space and we compare the DeepClean reconstruction directly to this PCA reconstruction for the same latent dimensions ( Figure 5 ).
Sample-wide artefact detection
We assessed the performance of our approach in detecting whether a 10-second sample of data contained an artefact or not via the mean squared error (MSE) between the sample and its reconstruction, with a suitable threshold. The goal of this work was to develop a 'blind' self-supervised classification procedure, and so any threshold on a metric applied to the reconstruction error must therefore be chosen independently of the test data. Figure 6 illustrates that values of metrics are generally not independent of hyperparameter choice. Therefore, without prior knowledge of a suitable threshold, an appropriate approach was to set a threshold based on the percentiles of the same metric calculated instead on the training data and their corresponding reconstructions. We pragmatically used the training set 90 th percentile as a threshold. We assessed the model performance by comparing the DeepClean classification to our annotation, using measures widely employed in clinical settings: accuracy, sensitivity and specificity. [12] and [18] ; see Discussion for further comments. Convolutional layers are desribed as 'n 1D conv. m', where n is the number of convolutional filters and m the kernel size; pooling and upsampling layers show the pool size; dropout layers show the dropout rate; and dense fully connected (FC) layers show the number of units. Upsampling layers are accompanied by cropping of the end of the layer output to match the corresponding encoder dimension size. Activation functions, such as the 'ReLu' activation, are shown where applicable; in all other cases, the activation is linear. 'Ld' is the latent dimension.
Within-sample artefact detection
A finer dichotomy of artefacts can be found using a locally-defined metric within the reconstruction error and therefore we also calculated the MSE on a 1-second moving window (physiologically similar to one or two typical heartbeat periods). We made a distinction that if the MSE on a particular window exceeded the threshold, then the entire window was identified as an artefact, and not just its midpoint. We defined a threshold for identifying an artefact as before, but used the training set 99 th percentile here. We provide justification of using this more stringent threshold in the Discussion. We assessed the performance by considering the proportion of each sample correctly identified with respect to our annotation. In addition, we considered the proportion of artefact within each sample that is correctly assigned as artefact, and similarly the proportion of the non-artefact sections that DeepClean does not incorrectly assign as artefact. In these last two measures, we ignored samples that contain no artefact and samples that contain only artefact respectively. These are analogous to the binary classification measures.
Results
We work with ABP waveform data from a single anonymised (adult) patient monitored almost continuously throughout a stay of several days (486,984 seconds) in the ICU. We marked 11,082 seconds of 486,984 seconds (2.28%) as grossly abnormal in preprocessing, leaving training and validation sets of 37,821 and 4,728 10-second samples. Training required under 10 minutes of computation time on average, although this increased with latent dimension. Subsequent prediction, on test data or on new data, is inexpensive and requires only milliseconds. Our annotation marked 130 test samples out of 200 as containing an artefact. Reconstruction Figure 5 shows example reconstructions for our model and PCA for comparison. DeepClean accurately reconstructed a typical sample for only a small number of latent variables, illustrating its superiority as an efficient data compression technique over PCA, which performed poorly for a small number of principal components but improved as the number of principal components increased. In particular, DeepClean captured the presence of the dicrotic notch and subsequent diastolic peak ( Figure 5 ) with only a two-dimensional latent space, whilst significantly more principal components are needed for PCA to encode sub-pulse components. Additionally, the PCA reconstruction for a large number of principal components contains high-frequency elements not present in the signal or the smoother DeepClean reconstruction.
Sample-wide artefact detection
DeepClean substantially outperformed the baseline PCA in sample-wide artefact detection in model sensitivity (Table  1) , using our training-set defined threshold. Whilst we give this heuristic for identifying a suitable threshold, we also provide receiver operating characteristic (ROC) curves to show the effect of varying it (Figure 7) , and DeepClean had a significantly higher ROC area under the curve (AUC) than PCA. There is in general a clear distinction between the Table 1 : Assessment of the classification of samples as containing an artefact or not, for both PCA and DeepClean (VAE). ROC AUC is the area under the receiver operating characteristic curve ( Figure 7 ). Both methods had comparable specificity, i.e. correctly identifying non-artefact data as such, with PCA performing slightly better. However, DeepClean alone can identify artefactual data as such, with high sensitivity.
log-MSE of artefacts and valid data for the DeepClean reconstruction, since DeepClean is able to distinguish samples similar to and unlike those belonging to the underlying process and generative model of training set data. In contrast, the range of log-MSE values for PCA reconstructions were similar for both training set and test set artefacts, so the latter cannot be easily identified in this way. One explanation for this is that VAE regularisation enforces a localised latent distribution and penalises samples with representations outside of this distribution, but there is no mechanism in PCA that localises the projections of training data and prevents latent representations extrapolated along their principal axis from providing a sufficiently good reconstruction. In both cases, the non-artefact test samples followed a similar distribution to the training data, as might be expected, and therefore the specificity was generally be close to the training set 90 th percentile threshold. As PCA reconstructions have higher error than DeepClean unless the number of principal components is very large, the threshold was generally much lower for DeepClean than PCA and therefore a poor DeepClean reconstruction may be identified as an artefact when an identical reconstruction from PCA may not. Sample log-MSE Figure 6 : Log-MSE values for both PCA and DeepClean, with increasing latent dimension. The distribution of training set log-MSE is shown with the training set 90 th percentile threshold. The test samples are split into those annotated as artefacts and not, and shown separately. The 'ground truth' artefacts that lie below the threshold and non-artefacts above the threshold were samples that were incorrectly identified, and were false negatives and false positives respectively. Therefore, the proportion of test artefacts points above the threshold is the sensitivity and the proportion of test non-artefacts below the threshold is the specificity.
Within-sample artefact detection
Precisely identifying artefacts within each sample is a more difficult problem and both PCA and DeepClean performed less well in this task (Table 2 ). For almost half of the test samples, the entire sample was classified completely (100%) correctly by DeepClean across all latent dimensions, corresponding to test samples that were clearly either entirely artefact or entirely valid signal. PCA was able to classify some of these samples completely correctly but also completely incorrectly classified others. Some examples of the DeepClean artefact detection compared to our annotation are provided in Figure 8 . Ideally, we would like the reconstruction error to be small for any non-artefact section within the sample and to otherwise provide an approximation for the 'true' signal in the absence of the artefact, as can be seen in the top centre reconstruction. The reconstruction in the top right, however, fails to do so. This task is non-trivial for DeepClean, as discussed later.
Discussion
We have demonstrated the use of a VAE to clean ABP signals in a self-supervised manner with only a gross preprocessing step required at model training, suggesting a clear potential role for deep neural networks in this application area. We have demonstrated high sensitivity and specificity for identification of samples containing artefact and also good performance at the harder task of identifying sub-sections of invalid data within each sample. DeepClean can impute missing data and we have demonstrated that it outperforms PCA at generating accurate reconstructions from a latent representation, suggesting a route to imputation via this latent space.
Unlike a recent study [20] , which employed a stacked convolutional autoencoder (SCAE) combined with a CNN, our approach does not require pulse pre-segmentation (which is in itself a difficult task requiring heuristics) or a supervised final classification network. Furthermore since DeepClean functions in the time domain, it avoids the quadratic complexity of first mapping the pulse morphology to a 2-dimensional space.
We decided to split the data into 10-second samples for training and prediction. A sample of this length should include a sufficient number of beats that the model can learn and generalise the structure of the waveform, and therefore distinguish artefacts that occur over similar or longer timescales. It is important that the model recognises clinical events as part of the same generative process, and so does not classify these as artefacts. Failure to flag a clinical event that has been incorrectly identified as a signal artefact risks delayed intervention and treatment. Whilst such events are Table 2 : Assessment of the classification of artefacts within each sample, for both PCA and DeepClean (VAE). For each sample, we calculated the proportion of that sample that was correctly identified with respect to our manual annotation, and we report the average across all samples. In addition, we show the proportion of artefactual data within the sample that is correctly identified as being an artefact, and similarly for non-artefactual data (with 'within sample' abbreviated to 'w.s.'). Finally, we show the proportion of samples within which the entirety of the sample was correctly (100%) identified.
. characterised by sudden changes across multiple frequency bands concurrently, the structure of the waveform during a clinical event is largely retained within a sample of this length, so it is a suitable choice. There may be a range of appropriate values when determining a suitable sample length, within the above considerations.
We sought a principled approach in selecting a suitable cutoff for any metric defined on the reconstruction error to determine an artefact, given that this choice appears dependent on the latent dimension. By decreasing the threshold on a metric, we classify more samples as artefacts, regardless of the correctness of this classification, and will therefore increase the specificity at the cost of decreasing the sensitivity (Figures 6 and 7) . We set a more stringent threshold for the task of identifying artefacts within each sample. We reasoned that it is useful practically to more closely restrict the number of false positive identifications in this setting, since, across an entire dataset, falsely identifying a small section of many samples would result in disproportionately many instances of DeepClean-identified false artefacts than we would expect to find under the sample-wide test. In addition, compared to the distribution of this metric across the training set, artefacts should in general lie further away in the distribution tail than in the sample-wide case, since we are averaging over a smaller number of points. For example, the upper centre sample in Figure 8 was classified as containing an artefact in our first test, even with only a small contribution to the MSE from the first half of this sample. In contrast, 1-second window MSE values for the second half of this sample were more extreme values as they were not weighted by the non-artefact section, so we can afford a much stricter threshold to determine these regions.
Artefact detection is often only the first part of handling invalid data, as simply removing artefacts creates missing data that may also bias further analysis. One major attraction of a VAE-based generative model is that we can generate realistic, synthetic data by sampling directly from the latent distribution. An obvious solution then is to replace an artefact sample with its reconstruction, and further, we can also set missing data to a fixed non-viable value and treat this as an artefact similarly. This may only be suitable for a given sample if, for any artefacts within that sample, the reconstruction can approximate (with large reconstruction error) the underlying signal behaviour that would be expected in the absence of the artefact mechanism, whilst simultaneously maintaining a small error for any non-artefact regions in the same sample (e.g. Figure 8 , upper centre). DeepClean is successful at this task for some samples and the latent representation of artefacts helps to explain why it sometimes struggles for others. Figure 4 shows that many of the representations of artefact test samples lie outside of the well-structured VAE latent distribution. In imposing the generative model on new data that does not come from the same process or mechanism as the training data, the probability that an artefactual sample is generated by latent variables that are similar to those of valid data is very low and, as a result, the artefactual sample is forced to have a latent representation with vanishingly small probability mass.
As the model has spent little or no time training this region of the distribution, the reconstruction is therefore very unlike that of any valid data, and we cannot then impute using the resulting reconstructions as neither latent representation nor reconstruction are meaningful or representative of the underlying 'true' behaviour. Density-based anomaly detection methods, which identify anomalies by the sparsity of the region of space in which they occupy, may be useful to recognise artefacts for which the reconstruction is not suitable for this reason. An alternative is to track the trajectory of a patient in the latent space and sample at points close to this trajectory when an artefact has been identified but further work is needed to understand the structure of the latent space. For example, β-VAEs [21, 22] can improve the ability of the network to disentangle meaningful features in the data via constrained optimisation.
Limitations
We have considered expert manual mark-up for 'ground truth' artefact assignment. Some artefacts are clearly identifiable to clinicians because their signal profile is so extreme. For example, blood sampling or subsequent flushing of the arterial line, which may be very variable in profile but will clearly contain signal excursions which are unphysiological.
There are other signals that are not so clear-cut to categorically assign as artefact. Patient movement may introduce vibration, which in the extreme may render the signal unusable but in less severe cases often simply decreases the signal-to-noise ratio. VAEs perform well at de-noising, particularly with additional modifications [23] , but whether such signals are identified as artefacts is to some extent arbitrary. Changes in the resonant properties of the ABP transduction system due to blood clots or bubbles represent another difficulty. This may occur as a result of 'over-damping' (mean pressure preserved) or attenuation [24] (mean pressure not preserved): in either case the pulse amplitude is reduced and high-frequency features are lost. Since the presence of high frequency features varies with cardiac output, it is impossible to absolutely ascribe such regions as valid or otherwise. As a result of these considerations, a good gold standard is lacking and therefore imposes limitations on our ability to rigorously evaluate model performance.
There are a number of improvements that could be made to our framework. We have focused little on optimising hyperparameter and architecture choices, using deep CNNs for both encoder and decoder that we have deliberately kept small relative to the deep generative learning literature. However, we expect the gains from increasing the network size or complexity, for example, to be marginal in this application domain. That being said, one particularly interesting hyperparameter is the dimension of the latent space. We have shown that DeepClean performs well for intermediate latent space dimensions but this may warrant further exploration, particularly if it is possible to tune the network sufficiently such that disentangled interpretable features are encoded in the latent space.
We chose the ABP signal as a test case for several reasons. Firstly, it is particularly artefact-prone due to the effects of movement and flushing on the fluid filled catheter system typically employed. Secondly, ABP is of universal physiological importance: especially the extremes of ABP (hypo-and hypertension), which are particularly influenced by artefacts. Finally, ABP morphology tends to have good signal to noise properties. The performance of our model with other types of physiological signal is an area of future investigation and optimisation. We have trained and tested our system on available data, from a patient in sinus rhythm which is strongly periodic over the sample lengths considered. It is important to establish whether a generative model trained on the waveforms from one patient is able to generalise to other patients and maintain similar performance. Though training separate models for each patient is more cost-efficient than a manual annotation, it is obviously much more beneficial if artefact prediction is possible without requiring training data from each patient. However, if retraining is required, it is possible to initialise from a previous model and so not necessary to train from scratch. Such transfer of learning between patients either requires identical recording frequencies, which is common with standardised monitoring software, or an interpolation scheme such that the length of samples corresponding to a fixed time interval is constant. Additionally, the performance of this framework on data from patients with more irregular (e.g. patients with arrhythmias, such as atrial fibrillation or multiple ectopics) has not been determined and will be the subject of future work.
Conclusion
This work offers a promising alternative to the identification of signal artefacts in physiological waveforms from intensive care multimodality monitoring. This study proposes DeepClean, a self-supervised generative deep learning approach to identify and reject these artefacts. This method performs strongly in identifying samples containing an artefact from an ICU ABP waveform. High-frequency waveforms are central to clinical prognosis of the patient state, and clinical parameters associated with outcome are derived from features of the signals. Analysis that may inform care and treatment is susceptible to biases that arise from unidentified signal artefacts, and subsequent potential misdiagnosis of clinical events could result in aggressive yet unnecessary clinical intervention. Further, by removing artefacts within the signal, an improvement in the prognostic ability of a real clinical event will reduce the high false positive rate of alarms in ICU monitoring systems, improving the conditions in which clinical staff can provide the best possible care for patients. Real-time identification of artefacts and signal irregularities is absolutely critical and DeepClean suggests that generative deep learning can have an important role in this task.
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